CBPO [China Biologic Products] SC 13D/A: REPURCHASE AGREEMENT Agreement Company Seller Seller Affiliate Parties

[REPURCHASE AGREEMENT Agreement Company Seller Seller Affiliate Parties Party This REPURCHASE AGREEMENT (this “ Common Stock WHEREAS, Seller desires to sell to the Company, and the Company desires to repurchase and acquire from Seller, an aggregate of 2,500,000 shares of common stock (“ Remaining Shares WHEREAS, after giving effect to the transactions contemplated by this Agreement, Seller will still own] [Siu Ling Chan 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP £ (a) £ (b) 3. SEC USE ONLY 4. SOURCE OF FUNDS PF (See Item 3 of this Schedule 13D) 5.]

CBPO [China Biologic Products] 8-K: (Original Filing)

[REPURCHASE AGREEMENT Agreement Company Seller Seller Affiliate Parties Party This REPURCHASE AGREEMENT (this “ Common Stock WHEREAS, Seller desires to sell to the Company, and the Company desires to repurchase and acquire from Seller, an aggregate of 2,500,000 shares of common stock (“ Remaining Shares WHEREAS, after giving effect to the transactions contemplated by this Agreement, Seller will still own] []

CBPO [China Biologic Products] 8-K: REPURCHASE AGREEMENT Agreement Company Seller Seller Affiliate Parties

[REPURCHASE AGREEMENT Agreement Company Seller Seller Affiliate Parties Party This REPURCHASE AGREEMENT (this “ Common Stock WHEREAS, Seller desires to sell to the Company, and the Company desires to repurchase and acquire from Seller, an aggregate of 2,500,000 shares of common stock (“ Remaining Shares WHEREAS, after giving effect to the transactions contemplated by this Agreement, Seller will still own] []

CBPO [China Biologic Products] SC 13G: GL Trade Investment Limited 2 CHECK THE APPROPRIATE

[GL Trade Investment Limited 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) x 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 1,469,817 6 SHARED VOTING POWER 0]

CBPO [China Biologic Products] SC 13G: (Original Filing)

[GL Trade Investment Limited 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) x 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 1,469,817 6 SHARED VOTING POWER 0]

CBPO [China Biologic Products] 8-K: (Original Filing)

[CHINA BIOLOGIC PRODUCTS, INC. DIRECTOR AGREEMENT Agreement Company Mr. David Li Director THIS AGREEMENT (The “ BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of a director and the Director desires to be so appointed for such position and to perform the] []

CBPO [China Biologic Products] 8-K: CHINA BIOLOGIC PRODUCTS, INC. DIRECTOR AGREEMENT Agreement Company

[CHINA BIOLOGIC PRODUCTS, INC. DIRECTOR AGREEMENT Agreement Company Mr. David Li Director THIS AGREEMENT (The “ BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of a director and the Director desires to be so appointed for such position and to perform the] []

CBPO [China Biologic Products] 8-K: FOR RELEASE November 5, 2013 China Biologic Reports

[FOR RELEASE November 5, 2013 China Biologic Reports Financial Results for the Third Quarter and First Nine Months of 2013 --3Q13 Total Sales of $53.2 Million / 9M Total Sales Up 6.6%-- --3Q13 Operating Income Up 13.4% / 9M Operating Income Up 23.0%-- --3Q13 Operating Margin Up 520 bp to 43.6% / 9M Operating Margin Up to 46.3% -- --3Q13] []

CBPO [China Biologic Products] 10-Q: (Original Filing)

[] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [David (Xiaoying) Gao , the Chief Executive Officer of CHINA BIOLOGIC PRODUCTS, INC. (the “Company”), DOES HEREBY CERTIFY that: 1. September 30 , 201 3 2. 5 th day of November , 201 3 . David (Xiaoying) Gao Chief Executive Officer A signed original of this written statement required by Section 906 has been provided to China Biologic Products, Inc.] [Ming Yang , the Chief Financial Officer of CHINA BIOLOGIC PRODUCTS, INC. (the “Company”), DOES HEREBY CERTIFY that: 1. 3 2. 5 th day of November , 201 3 . Ming Yang Ming Yang Chief Financial Officer (Principal Financial Officer) A signed original of this written statement required by Section 906 has been provided to China Biologic Products, Inc. and]

CBPO [China Biologic Products] 10-Q:

[] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [David (Xiaoying) Gao , the Chief Executive Officer of CHINA BIOLOGIC PRODUCTS, INC. (the “Company”), DOES HEREBY CERTIFY that: 1. September 30 , 201 3 2. 5 th day of November , 201 3 . David (Xiaoying) Gao Chief Executive Officer A signed original of this written statement required by Section 906 has been provided to China Biologic Products, Inc.] [Ming Yang , the Chief Financial Officer of CHINA BIOLOGIC PRODUCTS, INC. (the “Company”), DOES HEREBY CERTIFY that: 1. 3 2. 5 th day of November , 201 3 . Ming Yang Ming Yang Chief Financial Officer (Principal Financial Officer) A signed original of this written statement required by Section 906 has been provided to China Biologic Products, Inc. and]

Skip to toolbar